Gender disparity in lipid target achievements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian Gulf

Ibrahim Al-Zakwani, Abdullah Shehab, Ali T. Al-Hinai, Wael Al Mahmeed, Mohamed Arafah, Omer Al-Tamimi, Mahmoud Al-Awadhi, Faisal Al Anazi, Haitham Amin, Khalid Al Nemer, Shorook Al Herz, Othman Metwally, Akram Alkhadra, Mohammed Fakhry, Hossam Elghetany, Abdel R. Medani, Afzal Hussein Yusufali, Obaid Al Jassim, Omar Al-Hallaq, Fahad Omar Ahmed S. Baslaib & 4 others Khalid Al-Waili, Khamis Al-Hashmi, Vasilios G. Athyros, Khalid Al-Rasadi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Few studies assessed gender disparity in lipid goal attainment in the Arabian Gulf. Hence, we estimated gender gaps in lipid target achievements among patients at high and very high atherosclerotic cardiovascular disease (ASCVD) risk in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS). Methods: The study (conducted between November 22, 2009 and July 7, 2010) included 4,384 patients (≥18 years) on lipid lowering drugs at high and very ASCVD risk status from outpatient clinics of 177 specialists and primary care physicians in 6 Arabian Gulf countries. Results: The overall mean age was 57±11 years and 40% (n=1763) were women. Women were more likely to have diabetes mellitus (84 vs 71%; p <0.001) and metabolic syndrome (49 vs 35%; p <0.001) compared with males. Women were less likely to achieve their low-density lipoprotein cholesterol (LDLC) (28 vs 32%; p = 0.002), high-density lipoprotein cholesterol (HDL-C) (42 vs 50%; p <0.001), and apolipoprotein B (Apo B) (38 vs 42%; p = 0.015) targets compared with men. In the very high ASCVD risk cohort, women were significantly less likely to achieve their LDL-C (20 vs 30%; p <0.001), non-HDL-C (34 vs 39%; p = 0.001) and Apo B (34 vs 41%; p <0.001) therapeutic targets compared with men. Conclusion: Women in the Arabian Gulf were less likely to achieve their lipid targets than men. The difference was more significant in the very high ASCVD risk group.

Original languageEnglish
Pages (from-to)51-58
Number of pages8
JournalCurrent Vascular Pharmacology
Volume15
Issue number1
DOIs
Publication statusPublished - 2017

Fingerprint

Cardiovascular Diseases
Lipids
Apolipoproteins B
Middle East
Primary Care Physicians
Ambulatory Care Facilities
Hypercholesterolemia
LDL Cholesterol
HDL Cholesterol
Diabetes Mellitus
Pharmaceutical Preparations
Therapeutics

Keywords

  • Apolipoprotein B
  • Arabs
  • Atherosclerosis
  • Cardiovascular diseases
  • LDL cholesterol
  • Non-HDL-C
  • Sex
  • Triglycerides
  • Women

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Gender disparity in lipid target achievements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian Gulf. / Al-Zakwani, Ibrahim; Shehab, Abdullah; Al-Hinai, Ali T.; Mahmeed, Wael Al; Arafah, Mohamed; Al-Tamimi, Omer; Al-Awadhi, Mahmoud; Al Anazi, Faisal; Amin, Haitham; Al Nemer, Khalid; Al Herz, Shorook; Metwally, Othman; Alkhadra, Akram; Fakhry, Mohammed; Elghetany, Hossam; Medani, Abdel R.; Yusufali, Afzal Hussein; Al Jassim, Obaid; Al-Hallaq, Omar; Baslaib, Fahad Omar Ahmed S.; Al-Waili, Khalid; Al-Hashmi, Khamis; Athyros, Vasilios G.; Al-Rasadi, Khalid.

In: Current Vascular Pharmacology, Vol. 15, No. 1, 2017, p. 51-58.

Research output: Contribution to journalArticle

Al-Zakwani, I, Shehab, A, Al-Hinai, AT, Mahmeed, WA, Arafah, M, Al-Tamimi, O, Al-Awadhi, M, Al Anazi, F, Amin, H, Al Nemer, K, Al Herz, S, Metwally, O, Alkhadra, A, Fakhry, M, Elghetany, H, Medani, AR, Yusufali, AH, Al Jassim, O, Al-Hallaq, O, Baslaib, FOAS, Al-Waili, K, Al-Hashmi, K, Athyros, VG & Al-Rasadi, K 2017, 'Gender disparity in lipid target achievements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian Gulf', Current Vascular Pharmacology, vol. 15, no. 1, pp. 51-58. https://doi.org/10.2174/1570161114666161003095139
Al-Zakwani, Ibrahim ; Shehab, Abdullah ; Al-Hinai, Ali T. ; Mahmeed, Wael Al ; Arafah, Mohamed ; Al-Tamimi, Omer ; Al-Awadhi, Mahmoud ; Al Anazi, Faisal ; Amin, Haitham ; Al Nemer, Khalid ; Al Herz, Shorook ; Metwally, Othman ; Alkhadra, Akram ; Fakhry, Mohammed ; Elghetany, Hossam ; Medani, Abdel R. ; Yusufali, Afzal Hussein ; Al Jassim, Obaid ; Al-Hallaq, Omar ; Baslaib, Fahad Omar Ahmed S. ; Al-Waili, Khalid ; Al-Hashmi, Khamis ; Athyros, Vasilios G. ; Al-Rasadi, Khalid. / Gender disparity in lipid target achievements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian Gulf. In: Current Vascular Pharmacology. 2017 ; Vol. 15, No. 1. pp. 51-58.
@article{2fa977ea02814925b6a9f2fc49cae15e,
title = "Gender disparity in lipid target achievements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian Gulf",
abstract = "Background: Few studies assessed gender disparity in lipid goal attainment in the Arabian Gulf. Hence, we estimated gender gaps in lipid target achievements among patients at high and very high atherosclerotic cardiovascular disease (ASCVD) risk in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS). Methods: The study (conducted between November 22, 2009 and July 7, 2010) included 4,384 patients (≥18 years) on lipid lowering drugs at high and very ASCVD risk status from outpatient clinics of 177 specialists and primary care physicians in 6 Arabian Gulf countries. Results: The overall mean age was 57±11 years and 40{\%} (n=1763) were women. Women were more likely to have diabetes mellitus (84 vs 71{\%}; p <0.001) and metabolic syndrome (49 vs 35{\%}; p <0.001) compared with males. Women were less likely to achieve their low-density lipoprotein cholesterol (LDLC) (28 vs 32{\%}; p = 0.002), high-density lipoprotein cholesterol (HDL-C) (42 vs 50{\%}; p <0.001), and apolipoprotein B (Apo B) (38 vs 42{\%}; p = 0.015) targets compared with men. In the very high ASCVD risk cohort, women were significantly less likely to achieve their LDL-C (20 vs 30{\%}; p <0.001), non-HDL-C (34 vs 39{\%}; p = 0.001) and Apo B (34 vs 41{\%}; p <0.001) therapeutic targets compared with men. Conclusion: Women in the Arabian Gulf were less likely to achieve their lipid targets than men. The difference was more significant in the very high ASCVD risk group.",
keywords = "Apolipoprotein B, Arabs, Atherosclerosis, Cardiovascular diseases, LDL cholesterol, Non-HDL-C, Sex, Triglycerides, Women",
author = "Ibrahim Al-Zakwani and Abdullah Shehab and Al-Hinai, {Ali T.} and Mahmeed, {Wael Al} and Mohamed Arafah and Omer Al-Tamimi and Mahmoud Al-Awadhi and {Al Anazi}, Faisal and Haitham Amin and {Al Nemer}, Khalid and {Al Herz}, Shorook and Othman Metwally and Akram Alkhadra and Mohammed Fakhry and Hossam Elghetany and Medani, {Abdel R.} and Yusufali, {Afzal Hussein} and {Al Jassim}, Obaid and Omar Al-Hallaq and Baslaib, {Fahad Omar Ahmed S.} and Khalid Al-Waili and Khamis Al-Hashmi and Athyros, {Vasilios G.} and Khalid Al-Rasadi",
year = "2017",
doi = "10.2174/1570161114666161003095139",
language = "English",
volume = "15",
pages = "51--58",
journal = "Current Vascular Pharmacology",
issn = "1570-1611",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Gender disparity in lipid target achievements in high and very high atherosclerotic cardiovascular disease risk patients in the Arabian Gulf

AU - Al-Zakwani, Ibrahim

AU - Shehab, Abdullah

AU - Al-Hinai, Ali T.

AU - Mahmeed, Wael Al

AU - Arafah, Mohamed

AU - Al-Tamimi, Omer

AU - Al-Awadhi, Mahmoud

AU - Al Anazi, Faisal

AU - Amin, Haitham

AU - Al Nemer, Khalid

AU - Al Herz, Shorook

AU - Metwally, Othman

AU - Alkhadra, Akram

AU - Fakhry, Mohammed

AU - Elghetany, Hossam

AU - Medani, Abdel R.

AU - Yusufali, Afzal Hussein

AU - Al Jassim, Obaid

AU - Al-Hallaq, Omar

AU - Baslaib, Fahad Omar Ahmed S.

AU - Al-Waili, Khalid

AU - Al-Hashmi, Khamis

AU - Athyros, Vasilios G.

AU - Al-Rasadi, Khalid

PY - 2017

Y1 - 2017

N2 - Background: Few studies assessed gender disparity in lipid goal attainment in the Arabian Gulf. Hence, we estimated gender gaps in lipid target achievements among patients at high and very high atherosclerotic cardiovascular disease (ASCVD) risk in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS). Methods: The study (conducted between November 22, 2009 and July 7, 2010) included 4,384 patients (≥18 years) on lipid lowering drugs at high and very ASCVD risk status from outpatient clinics of 177 specialists and primary care physicians in 6 Arabian Gulf countries. Results: The overall mean age was 57±11 years and 40% (n=1763) were women. Women were more likely to have diabetes mellitus (84 vs 71%; p <0.001) and metabolic syndrome (49 vs 35%; p <0.001) compared with males. Women were less likely to achieve their low-density lipoprotein cholesterol (LDLC) (28 vs 32%; p = 0.002), high-density lipoprotein cholesterol (HDL-C) (42 vs 50%; p <0.001), and apolipoprotein B (Apo B) (38 vs 42%; p = 0.015) targets compared with men. In the very high ASCVD risk cohort, women were significantly less likely to achieve their LDL-C (20 vs 30%; p <0.001), non-HDL-C (34 vs 39%; p = 0.001) and Apo B (34 vs 41%; p <0.001) therapeutic targets compared with men. Conclusion: Women in the Arabian Gulf were less likely to achieve their lipid targets than men. The difference was more significant in the very high ASCVD risk group.

AB - Background: Few studies assessed gender disparity in lipid goal attainment in the Arabian Gulf. Hence, we estimated gender gaps in lipid target achievements among patients at high and very high atherosclerotic cardiovascular disease (ASCVD) risk in the Centralized Pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS). Methods: The study (conducted between November 22, 2009 and July 7, 2010) included 4,384 patients (≥18 years) on lipid lowering drugs at high and very ASCVD risk status from outpatient clinics of 177 specialists and primary care physicians in 6 Arabian Gulf countries. Results: The overall mean age was 57±11 years and 40% (n=1763) were women. Women were more likely to have diabetes mellitus (84 vs 71%; p <0.001) and metabolic syndrome (49 vs 35%; p <0.001) compared with males. Women were less likely to achieve their low-density lipoprotein cholesterol (LDLC) (28 vs 32%; p = 0.002), high-density lipoprotein cholesterol (HDL-C) (42 vs 50%; p <0.001), and apolipoprotein B (Apo B) (38 vs 42%; p = 0.015) targets compared with men. In the very high ASCVD risk cohort, women were significantly less likely to achieve their LDL-C (20 vs 30%; p <0.001), non-HDL-C (34 vs 39%; p = 0.001) and Apo B (34 vs 41%; p <0.001) therapeutic targets compared with men. Conclusion: Women in the Arabian Gulf were less likely to achieve their lipid targets than men. The difference was more significant in the very high ASCVD risk group.

KW - Apolipoprotein B

KW - Arabs

KW - Atherosclerosis

KW - Cardiovascular diseases

KW - LDL cholesterol

KW - Non-HDL-C

KW - Sex

KW - Triglycerides

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85018431211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018431211&partnerID=8YFLogxK

U2 - 10.2174/1570161114666161003095139

DO - 10.2174/1570161114666161003095139

M3 - Article

VL - 15

SP - 51

EP - 58

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

IS - 1

ER -